関連する実験動画
Updated: Aug 12, 2026

11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
メチルプレドニソロンに対する受容体リンパ球の感受性は,死体腎臓移植の生存率に影響します
Lancet (London, England)
|June 7, 1986
まとめ
受信者のステロイド感受性は,腎臓移植の生存率に大きく影響します. メチルプレドニゾロンのED50値の低下は,混合リンパ球培養不適合腎臓移植において,よりよい移植生存率と相関する.
科学分野:
- ネフロロジーはネフロロジーを用います.
- 免疫学 免疫学とは
- 移植 移植 移植
背景:
- 腎臓移植は,末期腎疾患の治療に不可欠です.
- 混合リンパ球培養 (MLC) の互換性のない移植は,拒絶の課題に直面します.
- ステロイドを含む免疫抑制療法は,移植の生存に不可欠です.
研究 の 目的:
- 受信者のステロイド感受性と腎臓移植の結果の相関を調査する.
- 移植前のリンパ球のステロイド感受性が,移植後の移植の生存を予測するかどうかを判断する.
- MLC不適合性腎臓移植の生存に対するステロイド感受性の影響を評価する.
主な方法:
- 移植前のリンパ球におけるメチルプレドニゾロンのED50 (フィトヘマグルトニン反応を50%抑制する有効用量) を決定した.
- 低メチルプレドニソロンED50と高メチルプレドニソロンED50の受容者における1年間の移植生存を分析した.
- 従来の免疫抑制薬 (アザチオプリン,ステロイド) とサイクロスポリンベースのレジメンを受けた患者の比較結果.
主要な成果:
- 従来の免疫抑制 (p < 0.0002) の下でメチルプレドニゾロンのED50値が低い受容者の1年後の移植生存率 (86%対29%) は著しく高かった.
- シクロスポリンでED50値が低い受容者では,よりよい移植生存率 (76%対57%) の傾向が観察されましたが,統計的に有意ではありません.
- 受信者のステロイド感受性は,MLC-不一致性腎臓移植の生存に強く影響します.
結論:
- 移植前のステロイド感受性の決定は,腎臓移植の成功の貴重な予測指標です.
- ステロイドに対する感受性は,HLA-DR不一致性腎臓移植の受容者の選択を導くかもしれません.
- ステロイド感受性の評価は,パーソナライズされた免疫抑制剤の投与戦略を伝えることができます.
関連する概念動画
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

